254 related articles for article (PubMed ID: 6215861)
1. Complement: activation, consequences, and control.
James K
Am J Med Technol; 1982 Sep; 48(9):735-42. PubMed ID: 6215861
[TBL] [Abstract][Full Text] [Related]
2. Formation and function of the classical and alternative pathways of complement.
Ogle JD; Ogle CK
Clin Physiol Biochem; 1983; 1(2-5):194-213. PubMed ID: 6241120
[No Abstract] [Full Text] [Related]
3. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
4. Activation of the classical complement pathway by nephritic factor bound to the alternative pathway C3/C5 convertase.
Sobel AT; Cooper NR; Schreiber RD
J Immunol; 1979 Jan; 122(1):34-8. PubMed ID: 762421
[TBL] [Abstract][Full Text] [Related]
5. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
Medicus RG; Götze O; Müller-Eberhard HJ
J Exp Med; 1976 Oct; 144(4):1076-93. PubMed ID: 978134
[TBL] [Abstract][Full Text] [Related]
6. The functional inhibition of activated C1 inhibitor in normal human serum causes spontaneous consumption of the complement components C2, C3, C4, and factor B.
Gronski P; Bodenbender L; Kanzy EJ; Piepenbrock M; Seiler FR
Immunobiology; 1986 Apr; 171(3):252-62. PubMed ID: 3011651
[TBL] [Abstract][Full Text] [Related]
7. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
Fearon DT; Daha MR; Strom TB; Weiler JM; Carpenter CB; Austen KF
Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of activation of the classical pathway of complement by monoclonal IgE (DES). Restricted regulation of C4b by C4b-binding protein.
Saint-Remy JM
Eur J Immunol; 1984 Mar; 14(3):254-9. PubMed ID: 6608450
[TBL] [Abstract][Full Text] [Related]
9. The role of C1s, C1r and properdin in the initiation of the C3b-dependent feedback mechanism of the complement system.
Johnson U
Acta Pathol Microbiol Scand C; 1978 Apr; 86(2):73-8. PubMed ID: 696332
[TBL] [Abstract][Full Text] [Related]
10. Alternative complement pathway activation by C4b deposited during classical pathway activation.
Matsushita M; Okada H
J Immunol; 1986 Apr; 136(8):2994-8. PubMed ID: 2937839
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory effect of factor J on the alternative complement pathway.
González-Rubio C; Jiménez-Clavero MA; Fontán G; López-Trascasa M
J Biol Chem; 1994 Oct; 269(42):26017-24. PubMed ID: 7929312
[TBL] [Abstract][Full Text] [Related]
12. Activation of the alternative complement pathway.
Fearon DT
CRC Crit Rev Immunol; 1979 Nov; 1(1):1-32. PubMed ID: 162484
[No Abstract] [Full Text] [Related]
13. Inhibition of classical C5 convertase in the complement system by factor H.
Ito S; Tamura N
Immunology; 1983 Dec; 50(4):631-5. PubMed ID: 6228516
[TBL] [Abstract][Full Text] [Related]
14. Regulation and deregulation of the fluid-phase classical pathway C3 convertase.
Gigli I; Sorvillo J; Halbwachs-Mecarelli L
J Immunol; 1985 Jul; 135(1):440-4. PubMed ID: 3158705
[TBL] [Abstract][Full Text] [Related]
15. Regulation of C5 convertase activity by properdin, factors B and H.
Weiler JM
Immunol Res; 1989; 8(4):305-15. PubMed ID: 2531781
[No Abstract] [Full Text] [Related]
16. Two types of C3 nephritic factor: properdin-dependent C3NeF and properdin-independent C3NeF.
Tanuma Y; Ohi H; Hatano M
Clin Immunol Immunopathol; 1990 Aug; 56(2):226-38. PubMed ID: 2143128
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the alternative pathway of human complement by C1q.
Fishelson Z; Müller-Eberhard HJ
Mol Immunol; 1987 Sep; 24(9):987-93. PubMed ID: 2958692
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase.
Gigli I; Sorvillo J; Mecarelli-Halbwachs L; Leibowitch J
J Exp Med; 1981 Jul; 154(1):1-12. PubMed ID: 7019379
[TBL] [Abstract][Full Text] [Related]
19. Surface-dependent modulation by H of C5 cleavage by the cell-bound alternative pathway C5 convertase of human complement.
Fischer E; Kazatchkine MD
J Immunol; 1983 Jun; 130(6):2821-4. PubMed ID: 6222117
[TBL] [Abstract][Full Text] [Related]
20. C4-binding protein prevents spontaneous cleavage of C3 in sera of patients with hereditary angioedema.
Gronski P; Bodenbender L; Kanzy EJ; Seiler FR
Complement; 1988; 5(1):1-12. PubMed ID: 3338269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
